Case Reports in Dermatology
Conflicts of Interest
Self-Archiving, Funding Organizations (NIH, etc)
'Case Reports in Dermatology' is an open-access, peer-reviewed online-only journal and accepts original case reports in the field of dermatology.
Manuscripts written in English should be submitted online:
|Online Manuscript Submission|
Should you experience any problems with your submission, please contact the Editorial Office at
The preferred word processing package is Word for Windows®.
· Single Case
· Case Series
· Case and Review. For this section, the authors should provide a
historical background of at least 300 words. Number of references
should be at least 15.
· Educational Perspectives (by invitation only)
The inclusion of a paragraph on patients’ perspectives is strongly encouraged.
All articles in this journal are Open Access and meet the requirements of funding bodies or academic institutions. Articles are licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC). Articles can be read, downloaded, printed, and shared provided that use is for non-commercial purposes only, and proper credit is given to the authors as well as the original publisher. For research funded by the Wellcome Trust, Research Councils UK (RCUK) and other organizations with the same requirements, papers are published under the Creative Commons Attribution 4.0 International license (CC BY 4.0).
Please contact Karger's Open Access team at firstname.lastname@example.org with questions regarding your funding body or other matters.
Copyright of manuscripts is retained by the authors. Authors grant S. Karger AG, Basel, an exclusive unlimited license to publish the article under a Creative Commons license and identify S. Karger AG as the original publisher. Submission of an article for publication implies the authors’ consent to publication under the applicable Creative Commons license and the terms and conditions of the Publisher’s Licensing Agreement.
All manuscripts must be accompanied by a cover letter signed by all authors confirming that they all read the manuscript and agree to its publication in this form. Assurance should be given that the manuscript is not under simultaneous consideration by any other publication. A signed author's statement confirming patients' informed consent is required.
All manuscripts are subject to editorial review.
For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.
It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Conflicts of Interest
Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.
Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.
'Case Reports in Dermatology' is a peer-reviewed journal that uses a single-blind peer-review. Our aim is to provide authors with fast and constructive feedback regarding their submitted manuscript. The Editor-in-Chief and the international editorial board ensure a thorough and fair peer-review and the highest scientific publishing standards. Editors guide the peer-review process for papers in their areas of expertise. They select reviewers and make the decision whether to accept/reject or send a manuscript for revision after at least two review reports are received, and then a further decision to accept/reject or request further revisions following author revisions. Reviewers must have a recent publication record in the area of the submission, must not have published with the authors in the previous three years, and must not be from the same institution as the authors. The Editor-in-Chief is responsible to maintain high-quality peer-review of papers submitted to the journal.
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
Length: Manuscripts should be no more than 2,500 words, with up to 3 illustrations, 2 tables and a maximum of 15 references.
Title page: The first page of each paper should indicate the title, the authors' names, their affiliation, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: Please supply 3–10 key words in English that reflect the content of the paper.
Abstract: Each Case Report needs an abstract of no more than 250 words.
Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared as separate files, not embedded in the text.
Tables require a heading and figures a legend, prepared on a separate page.
Each illustration must be labeled with its number and the author's name. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling (final size), line drawings one of 800-1,200 dpi.
File names: All files should indicate the three letter extension appropriate to the file type (e.g. *.pdf, *.txt, *.xls).
Color illustrations are reproduced free of charge.
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as unpublished data and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).
(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
Matthews DE, Farewell VT: Using and Understanding Medical Statistics,
ed 3, revised. Basel, Karger, 1996.
(d) Edited books:
DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124137.
The publishing fee which includes the reproduction of color illustrations is CHF 680.00. Please note that receipt of payment is required for the editing and publishing process to begin.
Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Supplementary material will be hosted online at https://karger.figshare.com. Authors will be charged a processing fee of CHF 250.00 for supplementary material.
Karger permits authors of Open Access articles to post the final, published version of their articles in Open Access repositories or on other websites, in accordance with the relevant Creative Commons license. Re-posted Open Access articles must:
- Follow the terms of the relevant Creative Commons license
- Be linked to the final version on www.karger.com
- Include the following statement:
It is the author’s responsibility to fulfill these requirements.
Articles to be archived in PubMed Central for any reason, including funding requirements, must be submitted by Karger (see below):
Funding Organizations (NIH, etc)
The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits the final, published version of Open Access NIH-funded articles to PubMed Central (PMC) immediately upon publication. The paper usually receives a PMCID within approximately a month. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC. Authors should include information on their grant in the Acknowledgements section of their papers.
Manuscripts to be archived in PMC due to funding requirements will be submitted by Karger on the author’s behalf.
Proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of errors, are charged to the author.
It is the corresponding author's responsibility to keep co-authors informed on the publication status of the manuscript.